Skip to main content

Advertisement

Table 1 Clinical features of the study subjects

From: Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis

Characteristics   SSc (n = 51) Controls (n = 22)
   lcSSc(n = 33) dcSSc (n = 18)  
   47/4  
Sex (female/male)   32/1 15/3 18/4
   57.3 (14.1)  
Age (years), mean (SD)   59.3 (14.1) 55.1 (12) 44.1 (42.0)
Duration of disease   72.5 (1-240)  
month, range (min-max)   74.5 (6-240) 54.5 (1-144)  
Organ involvement (No) Esophagus 15 3  
  Heart 2 1  
  Kidney 0 0  
  Pulmonary hypertension 0 0  
  Pulmonary fibrosis 0 0  
  Sjögren syndrome 5 9  
ANA Specificity (No) Anti-topo I 11 13  
  Anti-ACA 10 14  
  Anti-U1 RNP 3 3  
Mean skin score (SD)   2.8 (3.4) 11.9 (9.4)  
Steroid treatment   4 5  
  1. ANA, antinuclear antibodies; Anti-topo I, anti-topoisomerase I antibody; Anti-ACA, anti-centromere antibody; Anti-U1 RNP, anti-uridine 1 ribonucleoprotein antibody; dcSSc, diffuse cutaneous systemic sclerosis; lcSSC, limited cutaneous systemic sclerosis; SD, standard deviation; SSC, systemic sclerosis.